Soligenix, Inc. (SNGX)
0.3602
+0.01
(+2.88%)
USD |
NASDAQ |
Oct 22, 10:43
Soligenix Market Cap : 7.794M for Oct. 22, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 21, 2026 | 7.575M |
| October 20, 2026 | 7.673M |
| October 19, 2026 | 7.437M |
| October 16, 2026 | 7.640M |
| October 15, 2026 | 7.684M |
| October 14, 2026 | 7.372M |
| October 13, 2026 | 7.244M |
| October 12, 2026 | 7.610M |
| October 09, 2026 | 7.867M |
| October 08, 2026 | 7.500M |
| October 07, 2026 | 7.649M |
| October 06, 2026 | 7.746M |
| October 05, 2026 | 7.768M |
| October 02, 2026 | 7.906M |
| October 01, 2026 | 7.872M |
| September 30, 2026 | 7.833M |
| September 29, 2026 | 7.898M |
| September 28, 2026 | 8.166M |
| September 25, 2026 | 8.315M |
| September 24, 2026 | 8.356M |
| September 23, 2026 | 8.333M |
| September 22, 2026 | 8.330M |
| September 21, 2026 | 8.049M |
| September 18, 2026 | 8.006M |
| September 17, 2026 | 8.116M |
| Date | Value |
|---|---|
| September 16, 2026 | 7.790M |
| September 15, 2026 | 7.792M |
| September 14, 2026 | 7.807M |
| September 11, 2026 | 7.876M |
| September 10, 2026 | 7.792M |
| September 09, 2026 | 7.941M |
| September 08, 2026 | 8.177M |
| September 04, 2026 | 8.222M |
| September 03, 2026 | 8.292M |
| September 02, 2026 | 8.259M |
| September 01, 2026 | 8.136M |
| August 31, 2026 | 8.222M |
| August 28, 2026 | 8.153M |
| August 27, 2026 | 8.222M |
| August 26, 2026 | 8.309M |
| August 25, 2026 | 8.765M |
| August 24, 2026 | 8.757M |
| August 21, 2026 | 8.677M |
| August 20, 2026 | 8.224M |
| August 19, 2026 | 8.246M |
| August 18, 2026 | 8.568M |
| August 17, 2026 | 8.248M |
| August 14, 2026 | 8.655M |
| August 13, 2026 | 8.242M |
| August 12, 2026 | 8.439M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.483B |
| Alnylam Pharmaceuticals, Inc. | 30.22B |
| Anika Therapeutics, Inc. | 276.09M |
| Savara, Inc. | 954.08M |
| Vericel Corp. | 2.098B |
Market Cap Related Metrics
| Price to Book Value | 1.173 |
| Price | 0.3602 |
| Earnings Yield | -353.8% |